Cargando…
Rare Malignant Indications for Liver Transplantation: A Collaborative Transplant Study Report
Introduction: Hepatocellular carcinoma (HCC) is by far the leading malignant indication for liver transplantation (LT). Few other malignancies, including cholangiocellular carcinoma (CCC), metastases from neuroendocrine tumors (NET), and sarcomas of the liver (LSAR), also are commonly accepted indic...
Autores principales: | Houben, Philipp, Schimmack, Simon, Unterrainer, Christian, Döhler, Bernd, Mehrabi, Arianeb, Süsal, Caner |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678034/ https://www.ncbi.nlm.nih.gov/pubmed/34926560 http://dx.doi.org/10.3389/fsurg.2021.678392 |
Ejemplares similares
-
The Differential Influence of Cold Ischemia Time on Outcome After Liver Transplantation for Different Indications—Who Is at Risk? A Collaborative Transplant Study Report
por: Lozanovski, Vladimir J., et al.
Publicado: (2020) -
Clinical Relevance of HLA Antibodies in Kidney Transplantation: Recent Data from the Heidelberg Transplant Center and the Collaborative Transplant Study
por: Süsal, Caner, et al.
Publicado: (2017) -
ABO-Incompatible Kidney Transplantation
por: Morath, Christian, et al.
Publicado: (2017) -
Split liver transplantation: Current developments
por: Hackl, Christina, et al.
Publicado: (2018) -
Can PIRCHE-II Matching Outmatch Traditional HLA Matching?
por: Unterrainer, Christian, et al.
Publicado: (2021)